by lythamcorp | Dec 11, 2024 | PolyPid, PolyPid News
PETACH TIKVA, Israel, Dec. 11, 2024 — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced a new research and development collaboration with...
by lythamcorp | Dec 10, 2024 | Healthcare, NeurAxis News
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will begin the process of commercially marketing RED and expects initial...
by lythamcorp | Dec 10, 2024 | Healthcare, Iradimed News
WINTER SPRINGS, Fla., Dec. 10, 2024 — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), today announced it has been ranked 24th on Forbes’ list of America’s Most Successful Small-Cap Companies 2025. Iradimed is a leader in the...
by lythamcorp | Dec 9, 2024 | Energy, Greenfire News, Greenfire Resources
The Company Also Announces Date of Annual and Special Meeting of ShareholdersCalgary, Alberta–(December 9, 2024) – Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) (“Greenfire” or the “Company”), a Calgary-based energy company...
by lythamcorp | Dec 6, 2024 | Energy, Greenfire News, Greenfire Resources
Calgary, Alberta–(December 5, 2024) – Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) (“Greenfire” or the “Company”), a Calgary-based energy company focused on the production and development of thermal energy resources from the...